NASDAQ
AIM ImmunoTech Inc. (AIM) has a current ratio of 0.53x as of Monday, May 25, 2026. This represents a 97.95% decrease compared to its 12-month average of 25.85x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.